We believe that ADAM12, ADAM17 mRNA and ADAM10 protein are worth further investigation as biomarkers for gastric cancer screening, and that players in the ADAM-NKG2D axis are worth investigation for cancer diagnostics and therapeutics. This evidence concerns the gene ADAM12 and cancer.